Weiss, L.
Dorman, K.
Boukovala, M.
Schwinghammer, F.
Jordan, P.
Fey, T.
Hasselmann, K.
Subklewe, M.
Bücklein, V.
Bargou, R.
Goebeler, M.
Sayehli, C.
Spoerl, S.
Lüke, F.
Heudobler, D.
Claus, R.
von Luettichau, I.
Lorenzen, S.
Lange, S.
Westphalen, C. B.
von Bergwelt-Baildon, M.
Heinemann, V.
Gießen-Jung, C. http://orcid.org/0000-0003-0537-1727
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 16 July 2023
Accepted: 17 July 2023
First Online: 25 July 2023
Declarations
:
: Lena Weiss: Honoraria: Roche, Servier, Travel support: AMGEN. Klara Dorman: Travel support: Servier, GSK, BMS, Honoraria: AstraZeneca. Ralf Bargou: Honoraria and Consulting: Amgen, Novartis, AvenCell, Astra Zeneca, Patent and royalty payments for blinatumomab. Florian Lüke: Honoraria: Janssen, Roche, MSD, Travel Grants: Janssen. CBW: CBW has received honoraria from Amgen, Bayer, BMS, Chugai, Celgene, Falk, GSK, MSD, Merck, Janssen, Ipsen, Roche, Servier, SIRTeX, Taiho; served on advisory boards for Bayer, BMS, Celgene, Janssen, MSD, Servier, Shire/Baxalta, Rafael Pharmaceuticals, RedHill, Roche; has received travel support by Bayer, Celgene, Janssen, RedHill, Roche, Servier, Taiho and research grants (institutional) by Roche. CBW serves as an officer for European Society of Medical Oncology (ESMO), Deutsche Krebshilfe (DKH), Arbeitsgemeinschaft internistische Onkologie (AIO) and is a member of the EU Commission expert group: Mission Board for cancer. Volker Heinemann: Honoraria: Merck, Amgen, Roche, Sanofi, SIRTEX, Servier, Pfizer, Pierre-Fabre, Astra-Zeneca; Consulting: Merck, Amgen, Roche, Sanofi, SIRTEX, BMS; MSD, Novartis, Boehringer Ingelheim, Servier, Pierre-Fabre, Celgene, Terumo; Research funding (for the institution): Merck, Amgen, Roche, Sanofi, Pfizer, Boehringer-Ingelheim, Sirtex, Bayer, Servier; Travel accommodation expenses: Merck, Roche, Amgen, SIRTEX, Bayer, Servier. Clemens Giessen-Jung: Honoraria and Travel accommodation expenses: Roche, Gruenenthal, Falk Foundation, Lilly Oncology.
: The study has been approved by the local ethics committee of the Ludwig-Maximilians-University Munich (22-1114 KB).